NEW YORK (AP) -- Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company....
king pharmaceuticalsPfizer will buy King Pharmaceuticals for $3.6BHeadlines from the Associated Press Tue, 10/12/2010 - 15:13
King Pharmaceuticals Settles and One Columnist Writes that Such ...Health Care Renewal Sat, 03/20/2010 - 15:46
Here we go again. The latest settlement in the parade was made by the Alpharma subsidiary of King Pharmaceuticals, as reported by Reuters: Alpharma Inc, a unit of King Pharmaceuticals (KG.N), has agreed to pay $42.5 million to resolve allegations that it gave kickbacks to doctors to prescribe the pain drug Kadian and misrepresented its safety and effectiveness, the Justice Department said on Tuesday. |
